Diffuse infiltrative lymphocytosis syndrome

From WikiMD's WELLNESSPEDIA


Diffuse infiltrative lymphocytosis syndrome
Synonyms DILS
Pronounce N/A
Specialty N/A
Symptoms Lymphadenopathy, Parotitis, Xerostomia, Peripheral neuropathy
Complications Non-Hodgkin lymphoma, Peripheral neuropathy
Onset Typically in HIV-positive individuals
Duration Chronic
Types N/A
Causes Associated with HIV infection
Risks HIV infection, particularly in individuals of African descent
Diagnosis Clinical evaluation, CD8+ T-cell infiltration in tissues
Differential diagnosis Sjögren's syndrome, Sarcoidosis, Non-Hodgkin lymphoma
Prevention N/A
Treatment Antiretroviral therapy, Corticosteroids
Medication N/A
Prognosis Variable, depends on HIV management
Frequency Rare, more common in HIV-positive individuals of African descent
Deaths N/A


Diffuse Infiltrative Lymphocytosis Syndrome (DILS) is a rare immunological condition characterized by the persistent infiltration of lymphocytes into various tissues, most notably the salivary glands and lungs. This syndrome is often associated with HIV infection and is considered one of the HIV-associated diseases. DILS shares some clinical features with Sjögren's syndrome, a more common autoimmune disorder affecting similar organs, but DILS is distinct in its etiology and association with HIV.

Etiology[edit]

DILS is primarily associated with HIV infection. The exact mechanism by which HIV leads to DILS is not fully understood, but it is thought to involve an abnormal immune response to the virus. In patients with DILS, there is a marked CD8+ lymphocytic infiltration into affected tissues, which differs from the primarily CD4+ lymphocytic infiltration seen in other HIV-related diseases.

Clinical Presentation[edit]

Patients with DILS typically present with symptoms related to the organs involved:

  • Salivary Glands: Enlargement of the parotid glands, dry mouth, and difficulty swallowing.
  • Lungs: Respiratory symptoms such as cough, dyspnea, and occasionally abnormal chest radiographs showing interstitial infiltrates.
  • Other Organs: Less commonly, DILS can affect the kidneys, liver, and eyes.

Diagnosis[edit]

Diagnosis of DILS involves a combination of clinical evaluation, imaging studies, and laboratory tests:

  • HIV Testing: Confirmation of HIV infection is crucial, as DILS is primarily associated with this virus.
  • Imaging: Ultrasound or MRI of the salivary glands and chest X-rays or CT scans for lung involvement.
  • Biopsy: Histological examination of affected tissues showing lymphocytic infiltration.

Treatment[edit]

Treatment of DILS focuses on managing symptoms and controlling the underlying HIV infection:

  • Antiretroviral Therapy (ART): Effective control of HIV with ART can lead to improvement of DILS symptoms.
  • Corticosteroids: These may be used to reduce inflammation in severely affected tissues.
  • Symptomatic Treatment: For example, pilocarpine for dry mouth or supplemental oxygen for respiratory distress.

Prognosis[edit]

The prognosis for patients with DILS varies. With effective HIV management, many patients experience stabilization of symptoms and some may see partial regression of glandular swelling and respiratory issues. However, the chronic nature of the disease can lead to complications over time.

Epidemiology[edit]

DILS is a rare condition, and its prevalence is not well-documented. It appears more frequently in individuals with poorly controlled HIV infection and is less common in the era of effective antiretroviral therapy.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.